Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 52, 3295-3299, June 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bell, R. H.
Right arrow Articles by Longnecker, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bell, R. H., Jr.
Right arrow Articles by Longnecker, D. S.

Overexpression of Cholecystokinin Receptors in Azaserine-induced Neoplasms of the Rat Pancreas1

Richard H. Bell, Jr.2, Elna T. Kuhlmann, Robert T. Jensen and Daniel S. Longnecker3

Department of Pathology, Dartmouth Medical School, Hanover, New Hampshire 03756 [R. H. B., E. T. K., D. S. L.], and Digestive Diseases Branch, NIH, Bethesda, Maryland 20892 [R. T. J.]

Cholecystokinin (CCK) is a growth factor for normal pancreas. Numerous studies also suggest that CCK promotes pancreatic carcinogenesis in the rat. Our previous studies suggested that growth of preneoplastic pancreatic foci was stimulated by CCK more than that of normal pancreas. We hypothesized that such differential growth might be due to increased numbers of CCK receptors in neoplastic tissue.

Azaserine-induced pancreatic carcinoma (DSL6) had an increased high-affinity CCK receptor binding capacity of 122 ± 23 (SD) fmol/mg protein compared to 12 ± 2 fmol/mg protein in normal pancreas (P < 0.001). The Kd of the high-affinity site was 0.33 ± 0.04 nM for carcinoma and 0.46 ± 0.08 nM for normal pancreas (P < 0.01). The amount of cholecystokinin octapeptide (CCK-8) bound to high-affinity receptor was 8.6 ± 1.9 fmol/mg protein for DSL6 compared to 0.6 ± 0.2 fmol/mg protein in normal pancreas (P < 0.001).

Azaserine-induced premalignant nodules were compared to remaining internodular pancreas. Nodules demonstrated a mean high-affinity CCK receptor binding capacity of 38 ± 9 fmol/mg protein compared to 6 ± 3 fmol/mg protein in internodular pancreas (P < 0.001). The amount of CCK-8 bound to high-affinity receptor was 3.1 ± 0.8 fmol/mg protein in nodules compared to 0.6 ± 0.3 fmol/mg protein in internodular pancreas (P < 0.001).

Overexpression of high-affinity CCK-8 receptor in premalignant and malignant azaserine-induced tumors may result in a growth advantage relative to normal pancreas.

1 This project was supported by a grant from the Hitchcock Foundation (No. 250-94) and by NIH Grants ES-03687, CA 47327, and CA 23108, USPHS.

2 Present address: Department of Surgery (ML 558), University of Cincinnati College of Medicine, 231 Bethesda Avenue, Cincinnati, OH 45267.

3 To whom requests for reprints should be addressed, at Department of Pathology, Box 7600, Dartmouth Medical School, Hanover, NH 03756.

Received 9/18/91. Accepted 4/ 3/92.




This article has been cited by other articles:


Home page
Toxicol SciHome page
L. Dethloff, B. Barr, L. Bestervelt, S. Bulera, R. Sigler, M. LaGattuta, and F. de la Iglesia
Gabapentin-Induced Mitogenic Activity in Rat Pancreatic Acinar Cells
Toxicol. Sci., May 1, 2000; 55(1): 52 - 59.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1992 by the American Association for Cancer Research.